Last mentioned: Mar 12, 2026
Implementation
Phased rollout of R&D subsidies and stricter localized data requirements.
Expected Rollout
Full commercial availability of the next-generation uAI platform in the EU market.
Clinical Data Release
Presentation of multi-center validation studies for uAI oncology tools.
ECR 2026 Presentation
United Imaging Intelligence unveils its 'AI at Scale' strategy in Vienna.
ECR 2026 Opening
UII launches its 'Validating, Expanding, and Applying' theme in Vienna.
Official Launch
Formal adoption of the 15th Five-Year Plan focusing on high-end tech autonomy.
European Market Push
Expected increase in partnerships with European hospital networks following ECR showcase.
Drafting Phase
State Council finalizes the self-reliance mandates for the 15th Plan.
Portfolio Expansion
UII expands uAI platform to include advanced neuro and oncology suites.
Global Expansion
UII secures major CE and FDA clearances for core uAI modules.
14th Five-Year Plan
Initial push for domestic substitution in basic medical consumables.
United Imaging Intelligence (UII) showcased its latest AI-driven radiology solutions at the European Congress of Radiology (ECR) 2026, focusing on clinical validation and scalable deployment. The company's presentation highlighted a shift from experimental AI to integrated, full-stack clinical workflows.
United Imaging Intelligence (UII) unveiled a major expansion of its AI portfolio at the European Congress of Radiology (ECR) 2026, emphasizing clinical validation and large-scale deployment. The company's latest 'uAI' solutions aim to transition radiology AI from experimental tools to essential clinical infrastructure.
China has officially signaled a pivot toward total technological self-reliance in its 15th Five-Year Plan (2026-2030), prioritizing the domestic development of high-end medical devices and healthcare infrastructure. This strategic shift aims to insulate the nation’s healthcare system from external supply chain shocks and geopolitical pressures.